Apple Watch Adds Blood Pressure Alerts with AI-Powered Technology
ByAinvest
Friday, Sep 19, 2025 1:51 pm ET1min read
AAPL--
The new feature uses the watch’s optical heart sensor to analyze blood vessel responses to heartbeats. Running passively in the background, the algorithm reviews data collected over 30 days and notifies users if it detects consistent signs of high blood pressure. Apple noted that the tool may not identify every case of hypertension but could alert around one million users globally. The company plans to roll out the technology in more than 150 countries and regions, including the U.S. and the EU [1].
According to analysts, the introduction of this AI-driven feature has sparked interest among investors. Market analysts have been assessing Apple's prospects, with the average one-year price target for Apple Inc. (AAPL, Financial) standing at $243.48, including a high estimate of $305.00 and a low estimate of $175.00. These projections suggest a modest upside of 2.35% from the present stock price of $237.88, indicating potential for growth. The consensus recommendation from 50 brokerage firms is an average rating of 2.1, classifying Apple as an "Outperform" stock [2].
While the new feature is aimed at helping individuals identify high blood pressure early, experts stress that it should not replace a doctor's diagnosis. The feature is designed to complement traditional medical practices and provide users with additional data points to discuss with healthcare professionals.
Apple has added a new health feature to its Watch Series 11, which uses AI to warn users when they may have high blood pressure. The feature analyzes existing heart sensor data and will be available in over 150 countries. It is aimed at helping individuals identify high blood pressure early, but experts stress that it should not replace a doctor's diagnosis.
The U.S. Food and Drug Administration (FDA) has authorized Apple (AAPL.O) to launch a new hypertension detection feature on its smartwatches, the company said late Friday. Apple unveiled the blood pressure monitoring capability during its September 9 event, where it also introduced a slimmer iPhone Air and updated iPhone lineup. The feature will be available later this month on the Apple Watch Series 9, Series 10, Series 11, and the premium Ultra 2 and Ultra 3 models [1].The new feature uses the watch’s optical heart sensor to analyze blood vessel responses to heartbeats. Running passively in the background, the algorithm reviews data collected over 30 days and notifies users if it detects consistent signs of high blood pressure. Apple noted that the tool may not identify every case of hypertension but could alert around one million users globally. The company plans to roll out the technology in more than 150 countries and regions, including the U.S. and the EU [1].
According to analysts, the introduction of this AI-driven feature has sparked interest among investors. Market analysts have been assessing Apple's prospects, with the average one-year price target for Apple Inc. (AAPL, Financial) standing at $243.48, including a high estimate of $305.00 and a low estimate of $175.00. These projections suggest a modest upside of 2.35% from the present stock price of $237.88, indicating potential for growth. The consensus recommendation from 50 brokerage firms is an average rating of 2.1, classifying Apple as an "Outperform" stock [2].
While the new feature is aimed at helping individuals identify high blood pressure early, experts stress that it should not replace a doctor's diagnosis. The feature is designed to complement traditional medical practices and provide users with additional data points to discuss with healthcare professionals.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet